Life Sciences

Get timely insights into the fast moving Life Sciences industry with news highlighting breakthrough research, biotech advances, regulatory developments, and market shaping trends. This category delivers impactful updates that inform professionals as innovation, technology, and scientific discovery continue to reshape global health and the future of medical progress.

South Carolina Measles Cases Continue Rising in Widening Outbreak

South Carolina reported a rise in measles cases to 985, signaling a persistent public‑health challenge across the state and surrounding areas. State health officials confirmed six new infections, keeping the total increasing despite ongoing containment...

Publication Date: March 02, 2026 | Author Name: Mursalin Pathan | Industry: Life Sciences

ImmunityBio Expands ANKTIVA® (nogapendekin alfa inbakicept) in the EU.

ImmunityBio has taken decisive steps to accelerate ANKTIVA® (nogapendekin alfa inbakicept) access across Europe. Consequently, the company signed a commercial agreement and established an Irish unit to support the regional launch. Therefore, the expansion aims...

Publication Date: February 20, 2026 | Author Name: Mursalin Pathan | Industry: Life Sciences

RELIEVE UCCD LTE Data Show Promising Results in IBD Patients

Teva and Sanofi released positive findings from the RELIEVE UCCD LTE phase 2b long-term extension study evaluating duvakitug. This investigational human monoclonal antibody targets tumor necrosis factor-like ligand 1A (TL1A) and shows durable efficacy in inflammatory...

Publication Date: February 19, 2026 | Author Name: Mursalin Pathan | Industry: Life Sciences

FDA Clears RYBREVANT FASPRO™ for EGFR-Mutated Lung Cancer

The U.S. Food and Drug Administration has approved RYBREVANT FASPRO™ for once-monthly administration in adults with EGFR-mutated advanced non-small cell lung cancer. The decision marks a significant regulatory milestone for targeted lung cancer therapy. Moreover,...

Publication Date: February 18, 2026 | Author Name: Mursalin Pathan | Industry: Life Sciences

Lupin Partners with Spektus to Launch DeslaFlex™ Antidepressant

Global pharmaceutical leader Lupin Limited has signed a license and supply agreement with Spektus Pharma to commercialize DeslaFlex™ in Canada. This agreement allows Lupin to expand its Central Nervous System (CNS) portfolio and offer Canadian...

Publication Date: February 17, 2026 | Author Name: Mursalin Pathan | Industry: Life Sciences

Australia Approves Adrenaline Nasal Spray for Anaphylaxis

CSL Seqirus, part of the Australian biotechnology company, has launched a new adrenaline nasal spray called Neffy® for treating life-threatening anaphylaxis. It targets adults and children aged four years and older, weighing at least 15kg....

Publication Date: February 16, 2026 | Author Name: Mursalin Pathan | Industry: Life Sciences

Generic Semaglutide Patent Expiry Opens USD 546.42 Market

India’s pharmaceutical industry is set to benefit from the upcoming generic semaglutide patent expiry. Analysts predict that this milestone will improve patient access to diabetes and obesity therapies. Furthermore, it offers Indian drugmakers a competitive...

Publication Date: January 05, 2026 | Author Name: Mursalin Pathan | Industry: Life Sciences

Aurobindo Pharma Secures Growth Through ?325 Crore Deal

Hyderabad-based Aurobindo Pharma has finalized a ?325 crore deal to acquire Khandelwal Laboratories’ non-oncology prescription business. The acquisition, executed through its wholly owned subsidiary Auro Pharma Limited, marks a strategic step to strengthen domestic formulations...

Publication Date: January 05, 2026 | Author Name: Mursalin Pathan | Industry: Life Sciences

H5N1 Virus Threat Prompts Urgent Preparedness in India

Indian scientists have modeled how the H5N1 virus could spread to humans. It urges authorities to implement preventive measures swiftly to minimize outbreaks. Their research emphasizes the critical importance of early containment, continuous surveillance, and...

Publication Date: December 19, 2025 | Author Name: Mursalin Pathan | Industry: Life Sciences

Peptide Therapy Offers Transformational Hope for Fungal Eye Infections

Indian researchers have developed a promising peptide therapy that could dramatically improve treatment for fungal eye infections threatening vision nationwide. This therapy targets fungal keratitis, a severe corneal infection caused by fungi, and gives hope...

Publication Date: December 18, 2025 | Author Name: Mursalin Pathan | Industry: Life Sciences

News 1 to 10 | Total Count : 65

1

© The News and Media Division of The Insight Partners 2026 | All Rights Reserved | Privacy Policy